After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
Pfizer claims that Novo Nordisk is attempting to eliminate a potential rival in the GLP-1 drug market by acquiring Metsera, thereby stifling competition.